Open AccessPretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status
Author(s) -
Biniam Kidane,
Joanne Sulman,
Wei Xu,
Qin Kong,
Rebecca Wong,
Jennifer J. Knox,
Gail Darling
Publication year - 2016
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezw264
Subject(s) - medicine , cancer , quality of life (healthcare) , confidence interval , stage (stratigraphy) , receiver operating characteristic , performance status , esophageal cancer , proportional hazards model , gastroenterology , prospective cohort study , esophagus , oncology , paleontology , nursing , biology
Performance status [Eastern Cooperative Oncology Group (ECOG)] is a physician-assigned score indicating a patient's fitness for treatment. Functional assessment of cancer therapy-esophagus (FACT-E) is a patient-reported, health-related quality-of-life (HRQOL) instrument containing an oesophageal cancer subscale (ECS). Our objective was to assess the discriminative ability of pretreatment FACT-E and ECS when compared with performance status in predicting survival in patients with Stage II-III oesophageal cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom